AI assistant
Solid Biosciences Inc. — Director's Dealing 2025
Jan 14, 2025
33003_dirs_2025-01-13_326d59c0-ec63-4d42-9970-b27515b9fdfd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-01-09
Reporting Person: Tan Kevin (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-01-09 | Common Stock | M | 11250 | — | Acquired | 28862 | Direct |
| 2025-01-10 | Common Stock | S | 4073 | $3.8913 | Disposed | 24789 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-01-09 | Restricted Stock Units | $ | M | 11250 | Disposed | Common Stock (11250) | Direct |
Footnotes
F1: Restricted stock units convert to common stock on a one-for-one basis.
F2: Includes 4,152 and 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2024 and November 29, 2024, respectively.
F3: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The sales do not represent a discretionary trade by Mr. Tan.
F4: The restricted stock units were granted on January 9, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.